BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2221855)

  • 1. Problems with current recommendations for susceptibility testing of Haemophilus influenzae.
    Mendelman PM; Wiley EA; Stull TL; Clausen C; Chaffin DO; Onay O
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1480-4. PubMed ID: 2221855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid.
    Fuchs PC; Barry AL
    J Clin Microbiol; 1994 Nov; 32(11):2846-50. PubMed ID: 7852584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae.
    Mendelman PM; Henritzy LL; Chaffin DO; Lent K; Smith AL; Stull TL; Wiley EA
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1878-82. PubMed ID: 2610499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of ampicillin-intermediate strains of Haemophilus influenzae by using the disk diffusion procedure and current National Committee for Clinical Laboratory Standards guidelines.
    Heelan JS; Chesney D; Guadagno G
    J Clin Microbiol; 1992 Jul; 30(7):1674-7. PubMed ID: 1629320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ampicillin disk diffusion susceptibility testing of Haemophilus influenzae.
    Doern GV; Daum GS; Tubert TA
    J Clin Microbiol; 1987 Sep; 25(9):1675-8. PubMed ID: 3498738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing.
    Mendelman PM; Chaffin DO; Clausen C; Stull TL; Needham C; Williams JD; Smith AL
    Antimicrob Agents Chemother; 1986 Aug; 30(2):274-80. PubMed ID: 3490217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.
    Barry AL; Fuchs PC; Pfaller MA
    Antimicrob Agents Chemother; 1993 Jan; 37(1):14-8. PubMed ID: 8431012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.
    Jorgensen JH; Redding JS; Maher LA; Howell AW
    J Clin Microbiol; 1987 Nov; 25(11):2105-13. PubMed ID: 3500965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of five different susceptibility test methods for detecting antimicrobial agent resistance among Haemophilus influenzae isolates.
    Giger O; Mortensen JE; Clark RB; Evangelista A
    Diagn Microbiol Infect Dis; 1996 Mar; 24(3):145-53. PubMed ID: 8724400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
    Doern GV; Brueggemann AB; Pierce G; Holley HP; Rauch A
    Antimicrob Agents Chemother; 1997 Feb; 41(2):292-7. PubMed ID: 9021182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of aztreonam, imipenem, and amoxycillin-clavulanate against ampicillin-resistant Haemophilus influenzae.
    Powell M; Williams JD
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1871-3. PubMed ID: 3501940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 2001 May; 45(5):1585-8. PubMed ID: 11302835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of susceptibility of Haemophilus influenzae to beta-lactams by using HTM gelose (Haemophilus test medium)].
    Dabernat H; Seguy M; Delmas C
    Pathol Biol (Paris); 1993 Sep; 41(7):589-95. PubMed ID: 8255610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
    Zerva L; Biedenbach DJ; Jones RN
    J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of disk diffusion methods to detect low-level β-lactamase-negative ampicillin-resistant Haemophilus influenzae.
    Nørskov-Lauritsen N; Ridderberg W; Erikstrup LT; Fuursted K
    APMIS; 2011 Jun; 119(6):385-92. PubMed ID: 21569097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid.
    Jacobs MR; Bajaksouzian S
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):105-12. PubMed ID: 9294699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test.
    Jorgensen JH; Howell AW; Maher LA
    J Clin Microbiol; 1991 Jan; 29(1):109-14. PubMed ID: 1993744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
    Liljequist BO; Gezelius L
    Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing prevalence of ampicillin- resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan.
    Seki H; Kasahara Y; Ohta K; Saikawa Y; Sumita R; Yachie A; Fujita S; Koizumi S
    Chemotherapy; 1999; 45(1):15-21. PubMed ID: 9876205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.